Vizora日本語

Premier Anti-AgingPremier Anti-Aging Co., Ltd.4934東証グロース化学FY ending Jul 2025, consolidated, J-GAAP

Premier Anti-Aging FY ending Jul 2020 results

Premier Anti-Aging brought in ¥20.5B in revenue.

Out of every ¥100 of sales, about ¥8 is left as operating profit.

Revenue changed +71.9% from the prior year, operating profit +581.9%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +71.9% · profit +581.9%, calculated from disclosed figures.

Operating leverage: 8.09× (profit growth ÷ revenue growth)

What changed from last year

FY ending Jul 2019 → FY ending Jul 2020

Revenue
+71.9%¥11.9B → ¥20.5B
Gross profit
+69.7%¥9.71B → ¥16.5B
Operating income
+581.9%¥242.6M → ¥1.65B
Operating cash flow
Back to profit-¥238.9M → ¥338.2M
Free cash flow
Back to profit-¥275M → ¥196.3M

Where the money goes

FY ending Jul 2019 → FY ending Jul 2020

Where ¥100 of sales goes

For every ¥100 Premier Anti-Aging sells, how much goes where, and how much is kept.

FY ending Jul 2020
Cost of sales
¥20
SG&A
¥72
Operating profit
¥8
Net profit kept
¥6

Annual margin trends

Gross margin80.4%
FY ending Jul 2019: 81.4%81.4%FY ending Jul 2020: 80.4%80.4%FY19FY20
Operating margin8.1%
FY ending Jul 2019: 2.0%2.0%FY ending Jul 2020: 8.1%8.1%FY19FY20
Net margin5.6%
FY ending Jul 2019: 1.5%1.5%FY ending Jul 2020: 5.6%5.6%FY19FY20

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (1)

  • EDINET (FSA Japan)

    訂正有価証券報告書－第7期(令和1年8月1日－令和2年7月31日)

    ID S100KYP92021-03-15Open

Extracted from XBRL: 41 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image